Trials / Completed
CompletedNCT01035333
A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Albany College of Pharmacy and Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Orlistat | 60mg capsule three times a day for up to 6 months |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2009-12-18
- Last updated
- 2014-04-04
- Results posted
- 2014-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01035333. Inclusion in this directory is not an endorsement.